Cases Are Being Consolidated Against Sanofi By Alleged Zantac Cancer Sufferers

Cancer sufferers are joining multi-district litigation and filing suit against manufacturers of blood pressure, heartburn, and diabetes drugs that contain dangerous levels of NDMA

Tuesday, July 7, 2020 - For more than the last decade, Zantac (ranitidine) was the world's best-selling heartburn and acid reflux medicine earning Sanofi, the drug's manufacturer, billions of dollars in revenue every year. Today, thousands of lawsuits are being filed in every corner of the United States claiming plaintiffs have developed cancer from taking Zantac heartburn medicine. In 2019, online prescription drug testing pharmacy Valisure discovered elevated levels of N-nitrosodimethylamine (NDMA), a deadly carcinogen, in Zantac tablets at levels thousands of times greater than the FDA allowable limit of 96 nanograms per capsule. There is an ongoing debate as to the cause of the contamination and experts believe that either storing the product at high temperature, the interaction between the chemicals in the tablets and stomach nitrates, or contamination at overseas manufacturing plants is responsible for the anomalies. Valisure immediately filed a citizen's petition with the US Food and Drug Administration to have heartburn medications containing ranitidine taken off of the market and Sanofi immediately and voluntarily complied, allegedly to get to the bottom of the cancer accusations out of an abundance of caution. Later in 2019, the FDA itself demanded that several brands of ranitidine, including Zantac, be recalled. That's where we stand today as far as Zantac is concerned and the legal ramification of manufactures failing to warn the public of the drug's life-threatening health consequences could be staggering.

There is the potential for thousands of plaintiffs to come forward in the months to come if they have used Zantac for a prolonged time regularly and have developed any of the following types of cancer: "Stomach, bladder, breast, colorectal, intestinal, pancreatic, esophageal, prostate and many more. Cases are being accepted by Zantac Lawyers on a contingency fee agreement in most instances and are being consolidated into a multi-district litigation (MDL) to gather repetitive scientific evidence and to streamline discovery, and other administrative court proceedings.

If you have used Zantac or other over the counter or prescription heartburn and antacid medicine and have developed cancer you may wish to speak with a Zantac Cancer Lawyer and join one of the many local groups that have formed and have filed suit. According to DrugWatch.com, lawsuits are being filed against several leading heartburn medicine manufacturers such as Sanofi, Boehringer Ingelheim Pharmaceuticals, and Pfizer.

According to Drug Watch, "The newly formed MDL contains both individual cases alleging personal injuries and punitive class actions seeking refunds and other economic damages. Personal injury cases claim that consumers contracted liver, bladder, and other types of cancer as a result of ranitidine contamination with a chemical known as N-nitrosodimethylamine, or NDMA. While Zantac may cause other side effects, those are not part of these lawsuit claims. Consumers also accuse ranitidine manufacturers, sellers, and distributors of knowing that the medications exposed users to NDMA and hiding these dangers from the public.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.